Industri

Kashiv BioSciences to be acquired by Amneal Pharmaceuti...

Transaction to create integrated global biosimilars platform combining developm...

MSD teams up with Google Cloud on agentic AI transforma...

The collaboration aims to implement an agentic platform across MSD’s research an...

Safeguarding the pharma excipients supply chain

Adding excipient details to QR codes of the top 300 drugs may not be a tough ta...

Air vs. Paper in Healthcare Restrooms

For years, a quiet battle has been unfolding in public restrooms, one most peopl...

BioAegis and Prenosis partner for inflammatory disease ...

The collaboration will evaluate biomarkers and patient subgroups with improved r...

Health Canada approves Biocon’s two denosumab biosimilars

The approval covers Bosaya in a 60mg/ml prefilled syringe and Vevzuo in a 120mg/...

Off label drug use and physician liability

Dr Amit Kumar, Assistant Professor of Law, Maharashtra National Law University ...

Supriya Lifescience receives USFDA EIR with VAI classif...

Inspection cycle closed following February 2026 USFDA audit The post Supriya Li...

Lupin launches Dapagliflozin and Metformin extended-rel...

USFDA approves ANDA for bioequivalent version of Xigduo XR The post Lupin laun...

How Does Rubber Flooring Support Patient Safety and Exp...

Flooring is foundational and sets the tone for the space while also meeting the ...

Why Enterprise EHR Integrations Fail After Go-Live (And...

Healthcare organizations spend months, sometimes years, preparing for EHR integr...

Pfizer and Astellas secure FDA priority review for Padc...

The application aims to allow the use of this combination therapy for all patien...

Asahi Kasei acquires German company Aicuris

The move comes after Asahi Kasei signed a definitive agreement to acquire all is...

OneSource and Orbicular secure USFDA tentative approval...

Partnership progresses ANDA filing for generic version of Ozempic with manufact...

Zyax Chem acquires 26% stake in Gaymed Labs

Investment brings board representation and expansion plans in ophthalmic segmen...

India’s biopharma moment—If we get the ecosystem right

Krishna Sarma highlights the ecosystem requirements for advancing biopharma inn...